Technical Analysis for INMB - INmune Bio Inc.

Grade Last Price % Change Price Change
grade F 7.35 -0.41% -0.03
INMB closed down 0.41 percent on Thursday, February 14, 2019, on 81 percent of normal volume. The bears made the stock sink to a new 52-week low.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A N/A N/A
See historical INMB trend table...

Date Alert Name Type % Chg
Feb 14 New 52 Week Closing Low Bearish 0.00%
Feb 14 Hot IPO Pullback Bullish Swing Setup 0.00%
Feb 14 New 52 Week Low Weakness 0.00%
Feb 13 New 52 Week Closing Low Bearish -0.41%
Feb 13 Hot IPO Pullback Bullish Swing Setup -0.41%
Feb 12 Hot IPO Pullback Bullish Swing Setup -4.55%
Feb 11 Hot IPO Pullback Bullish Swing Setup -4.42%
Feb 11 Outside Day Range Expansion -4.42%
Feb 8 Inside Day Range Contraction -4.67%
Feb 7 New 52 Week Closing Low Bearish -2.78%

Older signals for INMB ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
INmune Bio (NASDAQ: INMB), Inc. is a clinical-stage biotechnology company developing therapies targeting the innate immune system in cancer. INmune Bio is developing two products platforms that reengineer the patient’s innate immune system’s response to their cancer, INKmune and INB03. INKmune is a Natural Killer (NK) cell therapeutic that primes the patient’s NK cells to attack developing disease. INB03 inhibits myeloid derived suppressor cells (MDSC), which often cause resistance to immunotherapy, such as anti-PD1 checkpoint inhibitors. INmune Bio’s product platforms target residual disease and utilize a precision medicine approach for treatment of a wide variety of hematologic malignancies and solid tumors.
Biotechnology Cancer Disease Solid Tumors Immunotherapy Immune System Cancer Treatments Hematologic Malignancies Tumors Of The Hematopoietic And Lymphoid Tissues Checkpoint Inhibitor
Is INMB a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 1 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 9.0
52 Week Low 7.0
Average Volume 17,714
200-Day Moving Average 0.0
50-Day Moving Average 0.0
20-Day Moving Average 0.0
10-Day Moving Average 0.0
Average True Range 0.0
ADX 0.0
+DI 0.0
-DI 0.0
Chandelier Exit (Long, 3 ATRs ) N/A
Chandelier Exit (Short, 3 ATRs ) N/A
Upper Bollinger Band 0.0
Lower Bollinger Band 0.0
Percent B (%b) 0.0
BandWidth 0.0
MACD Line 0.0
MACD Signal Line 0.0
MACD Histogram 0.0
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.03
Resistance 3 (R3) 7.98 7.72 7.91
Resistance 2 (R2) 7.72 7.54 7.74 7.87
Resistance 1 (R1) 7.53 7.44 7.63 7.58 7.84
Pivot Point 7.27 7.27 7.31 7.29 7.27
Support 1 (S1) 7.08 7.09 7.18 7.13 6.86
Support 2 (S2) 6.82 6.99 6.84 6.83
Support 3 (S3) 6.63 6.82 6.79
Support 4 (S4) 6.68